Fed. Circ. Says PTAB Right To Uphold Epilepsy Drug Patent
In a precedential opinion, the Federal Circuit on Friday upheld a patent related to UCB Inc.'s anti-epileptic drug Vimpat amid a challenge from three generic-drug makers, including Mylan Pharmaceuticals Inc., affirming...To view the full article, register now.
Already a subscriber? Click here to view full article